Skip to main content
. 2016 Dec 5;5(12):e004213. doi: 10.1161/JAHA.116.004213

Table 2.

HRs for Clinical Outcomes of Ablated Group Compared to Nonablated Group in the PSM Cohort

No. of Events PSM
Non‐Ablated Group (n=406) Ablated Group (n=406) HR (95% CI) P Value
Death 91 32 1.644 (1.081–2.501) 0.020
Stroke 8 5 1.412 (0.458–4.351) 0.548
Reoperation 38 10 2.664 (1.299–5.466) 0.008
Moderate‐to‐severe TR 152 66 1.436 (1.059–1.948) 0.020

HR indicates hazard ratio; PSM, propensity‐score matching; TR, tricuspid regurgitation.